butyloxycarbonyl-tryptophyl-methionyl-aspartyl-phenylalaninamide has been researched along with l 365260 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohme, A; Boudeau, P; Corringer, PJ; Ducos, B; Durieux, C; Roques, BP; Weng, JH | 1 |
| Bourin, M; Kõks, S; Soosaar, A; Vasar, E; Võikar, V | 1 |
2 other study(ies) available for butyloxycarbonyl-tryptophyl-methionyl-aspartyl-phenylalaninamide and l 365260
| Article | Year |
|---|---|
CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
Topics: Amino Acid Sequence; Animals; Benzodiazepinones; Brain; Cholecystokinin; Guinea Pigs; Male; Molecular Sequence Data; Peptide Fragments; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Structure-Activity Relationship; Tetragastrin | 1993 |
BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
Topics: Analgesics, Opioid; Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepinones; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Fear; Injections, Subcutaneous; Locomotion; Male; Maze Learning; Morphine; Naloxone; Narcotic Antagonists; Phenylurea Compounds; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Tetragastrin | 1999 |